…查看全文
$阿莱克萨制药(ALXA)$ 美东时间 2016-03-28 17:00 Q4 2015 Alexza Pharmaceuticals Inc Earnings Call 网页链接
$阿莱克萨制药(ALXA)$ 8-K/A [Amend] - Current report Filed: 2016-03-24 AccNo: 0001193125-16-516880 Size: 44 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$阿莱克萨制药(ALXA)$ 美东时间 2016-03-28 16:30 After Market Close:ALEXZA PHARMACT Earning Release 网页链接
$阿莱克萨制药(ALXA)$ 8-K - Current report Filed: 2016-03-09 AccNo: 0001193125-16-498600 Size: 49 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$阿莱克萨制药(ALXA)$ 8-K - Current report Filed: 2016-02-29 AccNo: 0001193125-16-483783 Size: 56 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$阿莱克萨制药(ALXA)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2016-02-26 AccNo: 0001341004-16-001174 Size: 149 KB 网页链接
$阿莱克萨制药(ALXA)$ D - Notice of Exempt Offering of Securities Filed: 2016-02-24 AccNo: 0001603018-16-000002 Size: 11 KB 网页链接
$阿莱克萨制药(ALXA)$ 8-K - Current report Filed: 2016-02-24 AccNo: 0001193125-16-474715 Size: 48 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 9.01: Financial Statements and Exhibits 网页链接
$阿莱克萨制药(ALXA)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-12 AccNo: 0001193125-16-462594 Size: 34 KB 网页链接
$阿莱克萨制药(ALXA)$ 8-K - Current report Filed: 2016-01-22 AccNo: 0001193125-16-435680 Size: 18 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接